People: Mannkind Corp (MNKD.O)

MNKD.O on Consolidated Issue listed on NASDAQ Global Market

7.12USD
22 Aug 2014
Price Change (% chg)

$0.03 (+0.42%)
Prev Close
$7.09
Open
$7.08
Day's High
$7.13
Day's Low
$6.96
Volume
4,197,983
Avg. Vol
12,056,470
52-wk High
$11.48
52-wk Low
$3.80

Search Stocks

Nordhoff, Henry 

Brief Biography

Mr. Henry L. Nordhoff is an Independent Director of MannKind Corporation., since March 18, 2005. Mr. Nordhoff retired as Chairman of the Board of Gen-Probe Incorporated, a clinical diagnostic and blood screening company, at the end of 2011, after serving as its Chairman since September 2002. He also served as Chief Executive Officer and President of Gen-Probe from July 1994 until May 2009. Prior to joining Gen-Probe, he was President and Chief Executive Officer of TargeTech, Inc., a gene therapy company that was merged into Immune Response Corporation. Prior to that, Mr. Nordhoff was at Pfizer, Inc. in senior positions in Brussels, Seoul, Tokyo and New York. He received a B.A. in international relations and political economy from Johns Hopkins University and an M.B.A. from Columbia University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alfred Mann

5,612,670

Hakan Edstrom

7,425,740

Matthew Pfeffer

4,484,180

Juergen Martens

5,034,710

David Thomson

4,399,980

Diane Palumbo

892,392
As Of 30 Dec 2013
Search Stocks